UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Type I Interferons in Autoimmune Disease

Annual review of pathology, 2019-01, Vol.14 (1), p.369-393

2019

Volltextzugriff (PDF)

Treatment of eosinophilic otitis media with pegylated interferon‐α 2a and 2b

The Laryngoscope, 2017-05, Vol.127 (5), p.1208-1216

2017

Volltextzugriff (PDF)

Investigation of Possible Link Between Interferon-α and Lyme Disease

Emerging infectious diseases, 2023-11, Vol.29 (11), p.2409-2409

2023

Volltextzugriff (PDF)

Artesunate alleviates Sjögren's Syndrome by inhibiting the interferon-α signaling in plasmacytoid dendritic cells via TLR-MyD88-IRF7

Biomedicine & pharmacotherapy, 2024-08, Vol.177, p.116885, Article 116885

2024

Volltextzugriff (PDF)

Interferon‐α Is Effective for Treatment of Minimal Residual Disease in Patients with t(8;21) Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: Results of a Prospective Registry Study

The oncologist (Dayton, Ohio), 2018-11, Vol.23 (11), p.1349-1357

2018

Volltextzugriff (PDF)

Microbiota regulation of viral infections through interferon signaling

Trends in microbiology (Regular ed.), 2022-08, Vol.30 (8), p.778-792

2022

Volltextzugriff (PDF)

Class 1 HDAC and HDAC6 inhibition inversely regulates CD38 induction in myeloma cells via interferon‐α and ATRA

British journal of haematology, 2019-06, Vol.185 (5), p.969-974

2019

Volltextzugriff (PDF)

European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment – Update 2019

European journal of cancer (1990), 2020-02, Vol.126, p.159-177

2020

Volltextzugriff (PDF)

Prognosis in early stage cutaneous T‐cell lymphoma treated with psoralen plus ultraviolet A irradiation and low‐dose interferon‐α: Long‐term efficacy and survival according to conventional and emerging clinical endpoints

Dermatologic therapy, 2022-10, Vol.35 (10), p.e15737-n/a

2022

Volltextzugriff (PDF)

Obesity intensifies sex-specific interferon signaling to selectively worsen central nervous system autoimmunity in females

Cell metabolism, 2024-08

2024

Volltextzugriff (PDF)

The effect of initial molecular profile on response to recombinant interferon‐α (rIFNα) treatment in early myelofibrosis

Cancer, 2017-07, Vol.123 (14), p.2680-2687

2017

Volltextzugriff (PDF)

European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022

European journal of cancer (1990), 2022-07, Vol.170, p.256-284

2022

Volltextzugriff (PDF)

Osteosarcoma treatment – Where do we stand? A state of the art review

Cancer treatment reviews, 2014-05, Vol.40 (4), p.523-532

2014

Volltextzugriff (PDF)

Hepatitis C – New drugs and treatment prospects

European journal of medicinal chemistry, 2019-03, Vol.165, p.225-249

2019

Volltextzugriff (PDF)

Hepatitis B core‐related antigen kinetics in chronic hepatitis B virus genotype D‐infected patients treated with nucleos(t)ide analogues or pegylated‐interferon‐α

Hepatology research, 2017-07, Vol.47 (8), p.747-754

2017

Volltextzugriff (PDF)

Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2016

European journal of cancer (1990), 2016-08, Vol.63, p.201-217

2016

Volltextzugriff (PDF)

Guanylate-Binding Protein 1: An Emerging Target in Inflammation and Cancer

Frontiers in immunology, 2020-01, Vol.10, p.3139-3139

2020

Volltextzugriff (PDF)

The Severity of Depressive Symptoms as an Independent Predictor of Sustained Virological Response During Treatment of Hepatitis C With Pegylated Interferon-α2a and Oral Ribavirin

Psychosomatic medicine, 2024-02, Vol.86 (2), p.124

2024

Volltextzugriff (PDF)

Anti-interferon-α neutralizing antibody is associated with nonresponse to pegylated interferon-α plus ribavirin in chronic hepatitis C

Journal of viral hepatitis, 2012-10, Vol.19 (10), p.694-703

2012

Volltextzugriff (PDF)

Melatonin prevented depressive-like behavior following cyclosporine A or interferon-α administration in mice

Hacettepe University Journal of the Faculty of Pharmacy, 2022-12

2022

Volltextzugriff (PDF)

Adjuvant low-dose interferon α2a with or without dacarbazine compared with surgery alone: a prospective-randomized phase III DeCOG trial in melanoma patients with regional lymph node metastasis

Annals of oncology, 2008-06, Vol.19 (6), p.1195-1201

2008

Volltextzugriff (PDF)

Tyrosine kinase inhibitors and interferon‐α increase tunneling nanotube (TNT) formation and cell adhesion in chronic myeloid leukemia (CML) cell lines

The FASEB journal, 2020-03, Vol.34 (3), p.3773-3791

2020

Volltextzugriff (PDF)

Both Type I and Type II Interferons Can Activate Antitumor M1 Macrophages When Combined With TLR Stimulation

Frontiers in immunology, 2018-11, Vol.9, p.2520-2520

2018

Volltextzugriff (PDF)

Natural history of chronic hepatitis B virus infection and long-term outcome under treatment

Liver international, 2009-01, Vol.29 (s1), p.100-107

Liaw, Yun-Fan

2009

Volltextzugriff (PDF)

Macrophages as host, effector and immunoregulatory cells in leishmaniasis: Impact of tissue micro-environment and metabolism

Cytokine: X, 2020-12, Vol.2 (4), p.100041-100041, Article 100041

Bogdan, Christian

2020

Volltextzugriff (PDF)

1 – 25 von 2.626

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.309)
Mit Volltextzugriff
(2.097)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

8 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.838)
Life Sciences & Biomedicine
(1.824)
Humans
(1.650)
Interferon-Α
(1.611)
Male
(921)
Female
(894)
Biological And Medical Sciences
(864)
Medical Sciences
(772)
Middle Aged
(711)
Adult
(665)
Interferon-Alpha - Therapeutic Use
(610)
Animals
(424)
Pharmacology. Drug Treatments
(417)
Aged
(411)
Oncology
(400)
Interferon-Alpha - Administration & Dosage
(340)
Interferon Α
(338)
Immunology
(319)
Interferon‐α
(318)
Recombinant Proteins
(316)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer
(73)
Journal Of Viral Hepatitis
(52)
Journal Of Hepatology
(45)
Digestive Diseases And Sciences
(39)
British Journal Of Haematology
(32)
Journal Of Medical Virology
(28)
Antiviral Research
(27)
Dermatology
(26)
Leukemia & Lymphoma
(25)
Journal Of Gastroenterology And Hepatology
(23)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(6)
... seit 90 Tagen
(12)

Menü

Weitere Dienste

Einstellungen

Type I Interferons in Autoimmune Disease

Treatment of eosinophilic otitis media with pegylated interferon‐α 2a and 2b

Investigation of Possible Link Between Interferon-α and Lyme Disease

Artesunate alleviates Sjögren's Syndrome by inhibiting the interferon-α signaling in plasmacytoid dendritic cells via TLR-MyD88-IRF7

Interferon‐α Is Effective for Treatment of Minimal Residual Disease in Patients with t(8;21) Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: Results of a Prospective Registry Study

Microbiota regulation of viral infections through interferon signaling

Class 1 HDAC and HDAC6 inhibition inversely regulates CD38 induction in myeloma cells via interferon‐α and ATRA

European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment – Update 2019

Prognosis in early stage cutaneous T‐cell lymphoma treated with psoralen plus ultraviolet A irradiation and low‐dose interferon‐α: Long‐term efficacy and survival according to conventional and emerging clinical endpoints

Obesity intensifies sex-specific interferon signaling to selectively worsen central nervous system autoimmunity in females

The effect of initial molecular profile on response to recombinant interferon‐α (rIFNα) treatment in early myelofibrosis

European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022

Osteosarcoma treatment – Where do we stand? A state of the art review

Hepatitis C – New drugs and treatment prospects

Hepatitis B core‐related antigen kinetics in chronic hepatitis B virus genotype D‐infected patients treated with nucleos(t)ide analogues or pegylated‐interferon‐α

Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2016

Guanylate-Binding Protein 1: An Emerging Target in Inflammation and Cancer

The Severity of Depressive Symptoms as an Independent Predictor of Sustained Virological Response During Treatment of Hepatitis C With Pegylated Interferon-α2a and Oral Ribavirin

Anti-interferon-α neutralizing antibody is associated with nonresponse to pegylated interferon-α plus ribavirin in chronic hepatitis C

Melatonin prevented depressive-like behavior following cyclosporine A or interferon-α administration in mice

Adjuvant low-dose interferon α2a with or without dacarbazine compared with surgery alone: a prospective-randomized phase III DeCOG trial in melanoma patients with regional lymph node metastasis

Tyrosine kinase inhibitors and interferon‐α increase tunneling nanotube (TNT) formation and cell adhesion in chronic myeloid leukemia (CML) cell lines

Both Type I and Type II Interferons Can Activate Antitumor M1 Macrophages When Combined With TLR Stimulation

Natural history of chronic hepatitis B virus infection and long-term outcome under treatment

Macrophages as host, effector and immunoregulatory cells in leishmaniasis: Impact of tissue micro-environment and metabolism

Suchergebnisse filtern